2-165832832-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000715282.1(GALNT3):​c.-109+13121A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.681 in 151,732 control chromosomes in the GnomAD database, including 35,928 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 35928 hom., cov: 29)

Consequence

GALNT3
ENST00000715282.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.09

Publications

5 publications found
Variant links:
Genes affected
GALNT3 (HGNC:4125): (polypeptide N-acetylgalactosaminyltransferase 3) This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. [provided by RefSeq, Jul 2008]
GALNT3 Gene-Disease associations (from GenCC):
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000715282.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.753 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000715282.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNT3
ENST00000715282.1
c.-109+13121A>G
intron
N/AENSP00000520447.1Q14435-1
ENSG00000229195
ENST00000428888.1
TSL:5
n.139+13121A>G
intron
N/A
ENSG00000235192
ENST00000741716.1
n.317-7858T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.681
AC:
103265
AN:
151616
Hom.:
35912
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.528
Gnomad AMI
AF:
0.851
Gnomad AMR
AF:
0.710
Gnomad ASJ
AF:
0.679
Gnomad EAS
AF:
0.564
Gnomad SAS
AF:
0.732
Gnomad FIN
AF:
0.757
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.758
Gnomad OTH
AF:
0.695
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.681
AC:
103323
AN:
151732
Hom.:
35928
Cov.:
29
AF XY:
0.680
AC XY:
50373
AN XY:
74130
show subpopulations
African (AFR)
AF:
0.527
AC:
21778
AN:
41300
American (AMR)
AF:
0.710
AC:
10828
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.679
AC:
2354
AN:
3468
East Asian (EAS)
AF:
0.564
AC:
2903
AN:
5148
South Asian (SAS)
AF:
0.732
AC:
3510
AN:
4792
European-Finnish (FIN)
AF:
0.757
AC:
7963
AN:
10518
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.758
AC:
51532
AN:
67954
Other (OTH)
AF:
0.698
AC:
1470
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1577
3153
4730
6306
7883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.736
Hom.:
68017
Bravo
AF:
0.670
Asia WGS
AF:
0.653
AC:
2270
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
9.2
DANN
Benign
0.43
PhyloP100
1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2060167;
hg19: chr2-166689342;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.